Tags

Type your tag names separated by a space and hit enter

[The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Wiad Lek. 2004; 57(5-6):263-6.WL

Abstract

This paper sums up recently published researches on the continuous subcutaneous insulin infusion (CSII) with the use of insulin pump in children and adolescents with diabetes type 1. Obtaining a balance in the organism metabolism in childhood and adolescence diabetology is nowadays one of the most important rules of the diabetes management in children. One of the modern ways to achieve that goal is the intensive insulin therapy model with use of the insulin pump. In this paper the advantages and disadvantages as well as the indications and contraindications for the CSII in children and adolescents with diabetes are widely discussed.

Authors+Show Affiliations

Jarosz-Chobot P
Kliniki Pediatrii, Endokrynologii i Diabetologii Dzieciecej, Slaskiej Akademii Medycznej w Katowicach.

MeSH

AdolescentChildDiabetes Mellitus, Type 1HumansHypoglycemiaHypoglycemic AgentsInfusion Pumps, ImplantableInjections, SubcutaneousInsulinInsulin Infusion SystemsRisk FactorsTreatment Outcome

Pub Type(s)

English Abstract
Journal Article
Review

Language

pol

PubMed ID

15518073

Citation

Jarosz-Chobot, Przemysława. "[The Use of Continuous Subcutaneous Insulin Infusion (CSII) With Personal Insulin Pumps in the Treatment of Children and Adolescents With Diabetes Type 1]." Wiadomosci Lekarskie (Warsaw, Poland : 1960), vol. 57, no. 5-6, 2004, pp. 263-6.
Jarosz-Chobot P. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. Wiad Lek. 2004;57(5-6):263-6.
Jarosz-Chobot, P. (2004). [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. Wiadomosci Lekarskie (Warsaw, Poland : 1960), 57(5-6), 263-6.
Jarosz-Chobot P. [The Use of Continuous Subcutaneous Insulin Infusion (CSII) With Personal Insulin Pumps in the Treatment of Children and Adolescents With Diabetes Type 1]. Wiad Lek. 2004;57(5-6):263-6. PubMed PMID: 15518073.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. A1 - Jarosz-Chobot,Przemysława, PY - 2004/11/3/pubmed PY - 2005/1/14/medline PY - 2004/11/3/entrez SP - 263 EP - 6 JF - Wiadomosci lekarskie (Warsaw, Poland : 1960) JO - Wiad Lek VL - 57 IS - 5-6 N2 - This paper sums up recently published researches on the continuous subcutaneous insulin infusion (CSII) with the use of insulin pump in children and adolescents with diabetes type 1. Obtaining a balance in the organism metabolism in childhood and adolescence diabetology is nowadays one of the most important rules of the diabetes management in children. One of the modern ways to achieve that goal is the intensive insulin therapy model with use of the insulin pump. In this paper the advantages and disadvantages as well as the indications and contraindications for the CSII in children and adolescents with diabetes are widely discussed. SN - 0043-5147 UR - https://www.unboundmedicine.com/medline/citation/15518073/[The_use_of_continuous_subcutaneous_insulin_infusion__CSII__with_personal_insulin_pumps_in_the_treatment_of_children_and_adolescents_with_diabetes_type_1]_ DB - PRIME DP - Unbound Medicine ER -